<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>NEUROBEHAVIOURAL AND HISTOMORPHOLOGICAL CHANGES IN  THE HIPPOCAMPUS AND CEREBELLUM OF WISTAR RATS TREATED  WITH ARTESUNATE AND AMODIAQUINE</title>
<link>http://hdl.handle.net/123456789/1733</link>
<description/>
<pubDate>Wed, 15 Apr 2026 17:51:49 GMT</pubDate>
<dc:date>2026-04-15T17:51:49Z</dc:date>
<item>
<title>NEUROBEHAVIOURAL AND HISTOMORPHOLOGICAL CHANGES IN  THE HIPPOCAMPUS AND CEREBELLUM OF WISTAR RATS TREATED  WITH ARTESUNATE AND AMODIAQUINE</title>
<link>http://hdl.handle.net/123456789/1734</link>
<description>NEUROBEHAVIOURAL AND HISTOMORPHOLOGICAL CHANGES IN  THE HIPPOCAMPUS AND CEREBELLUM OF WISTAR RATS TREATED  WITH ARTESUNATE AND AMODIAQUINE
POPOOLA, ABDULGAFAR NIYI
Artemisinin-based Combination Therapy (ACT) is among the best chemotherapeutic &#13;
options for malaria. Artesunate (AS) + Amodiaquine (AQ) is a commonly used ACT in &#13;
Nigeria, having good efficacy but with side effects involving memory loss and impaired &#13;
motor coordination ranging from acute to chronic. Reports on acute effect of AS+AQ &#13;
on the cerebellum and hippocampus are controversial and there is dearth ofinformation &#13;
on its delayed effect on these brain areas. This study was designed to evaluate the effects &#13;
of AS+AQ administration on neurobehaviour and morphology of the hippocampus and &#13;
cerebellum in Wistar rat after three-day acute treatment.&#13;
Eighty adult male Wistar rats (120±5g) were divided into 4 groups (n=20): Group A: &#13;
Control (CT: Distilled water), Group B: AS (4mg/kg), Group C: AQ (10mg/kg) and &#13;
Group D: AS (4mg/kg) + AQ (10mg/kg). Drugs were administered orally, once daily &#13;
for 3 days and animals monitored for 14 days. Weights of the animals were recorded. &#13;
Spatial memory and motor function were evaluated using Morris water-maze and fore limb grip tests, respectively. Animals were sacrificed by cervical dislocation on the 4&#13;
th&#13;
and 15th day. Collected blood samples were analysed for full blood count. Excised &#13;
cerebelli and hippocampi were processed for lipid peroxidation, biochemical markers of &#13;
oxidative stress including nitric oxide (NO). Histological (Haematoxylin &amp; Eosin) and &#13;
immunohistochemical techniques including Glial Fibrillary Acid Protein (GFAP) and &#13;
Cyclo-oxygenase II (COX-2) were also carried out. Data were analysed by ANOVA at &#13;
α0.05.&#13;
There was no significant variation in weight, neurobehavioural, haematological, &#13;
biochemical, morphological and immunohistochemical parameters between all groups &#13;
for the 3 days. At 14 days, AQ group had significant weight loss (30.40%) compared &#13;
with the CT group and significantly increased swimming time (22.86±2.70s) compared &#13;
with the CT group (4.14±0.74s). The AS (8.00±1.11s) and AQ (7.43±0.92s) had &#13;
significantly decreased grip time compared with CT (17.86±1.22s); AQ significantly &#13;
increased RBC (8.30±0.13/µL) and PCV (57.00±1.30%) compared with CT (RBC: &#13;
6.90±0.31/µL, PCV: 45.80±1.36%). Lipid peroxidation (per nmmol/g) increased &#13;
significantly in AS (233.07±2.26), AQ (257.14±2.06) and AS+AQ (223.32±1.99)&#13;
compared with CT (180.33±0.47). Ditto for NO (/µm/mg) (CT: 455.49±3.93, AS: &#13;
472.32±0.91, AQ: 525.74±10.11, AS+AQ: 480.95±2.917). The cerebellar Purkinje cell &#13;
population was significantly reduced in the AS (2.50±0.29) and AQ (1.25±0.25) groups &#13;
compared with CT (5.75±0.48), indicating pyknosis. Hippocampal Cornus Ammonis 1 &#13;
cells were significantly depopulated in the AS (10.75 ±0.48) and AQ (7.25±0.48) groups &#13;
compared to the CT (13.25±0.25) group, also indicating pyknosis. The GFAP &#13;
expressions (per %area) significantly increased in the cerebelli of AS (55.95±1.85) and &#13;
AQ (57.79±1.85) groups compared with CT (23.60±3.02) and in AS (76.81±7.19) and &#13;
AQ (83.71±3.78) groups of hippocampus compared with CT (55.19±3.86), indicating &#13;
astrogliosis. Compared with CT (59.36±5.61), AS (83.99±5.18) and AQ (88.32±0.88) &#13;
had significantly increased hippocampal COX-2 expression per %area, indicating &#13;
inflammation.&#13;
Neurobehavioural and morphological changes due to Artesunate and Amodiaquine &#13;
administration in Wistar rats were significant only after 14 days.
</description>
<pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/123456789/1734</guid>
<dc:date>2021-12-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
